Trump’s Executive Order on Drug Pricing
On Tuesday, President Donald Trump signed an executive order aimed at reshaping prescription drug pricing in the United States, targeting…
Category: Medical Policy Updates
The CMS Innovation Center: A Mixed Bag of Savings, Quality, and Lessons
The Center for Medicare and Medicaid Innovation (CMMI), established under the Affordable Care Act in 2010, was designed with a…
Cigna’s Strategic Shift: A New Era in Healthcare Diversification
The Cigna Group is making bold moves to ensure financial stability and long-term growth. With healthcare utilization normalizing post-pandemic, Cigna…
What Anthem Blue Cross’ Data Release Means for Providers
The cost of healthcare in New York City has long been a subject of scrutiny, with hospitals charging wildly different…
The Battle for Fair Pay: Why Providers are Taking on Blue Cross Blue Shield
In an unprecedented legal move, dozens of health systems, physician groups, and other healthcare providers have filed new antitrust lawsuits…
Medicaid Work Requirements: A Looming Crisis for Providers and Patients
The debate over Medicaid work requirements is heating up once again, with potential consequences that could ripple through the entire…
The DEA and HHS Delay Telehealth Buprenorphine Prescribing Rule Again
The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) have once again delayed the implementation…
How Direct-to-Patient Models Are Reshaping Healthcare
The American healthcare system is at a crossroads. Despite being one of the most expensive in the world, with spending…
Telehealth Extension: A Mixed Blessing for Providers
On March 15, Congress approved a federal spending bill that extends telehealth provisions through September 30, 2025. This extension is…